Clinical Trial

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.

Name: Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study. — clinical trial record (NCT07763912)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ACL25-IC003

Completed

View on ClinicalTrials.gov →

Summary

Prospective, longitudinal, single-dose, randomized, open-label, crossover 2x2, two treatments, two periods, two sequences controlled clinical study

Trial Details

NCT Number	NCT07763912
Lead Sponsor	ADIUM
Conditions	Bioequivalence
Enrollment	46 participants
Start Date	2025-11-24
Primary Completion	2025-12-05 (estimated)
Study Completion	2025-12-05 (estimated)
Updated on ClinicalTrials.gov	2026-08-14